SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 5th, 2024 • Immunic, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 5th, 2024 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of January 4, 2024 (the “Effective Date”) by and among Immunic, Inc., a Delaware corporation (the “Company”), and the Investors identified on Annex I attached hereto (each an “Investor” and collectively, the “Investors”).